Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 2/20 | 0.55 |
| ▸ | MMP9 | P14780 | 2/20 | 0.55 |
| ▸ | FKBP1A | P62942 | 4/20 | 0.52 |
| ▸ | ITGB1 | P05556 | 4/20 | 0.51 |
| ▸ | ITGA5 | P08648 | 3/20 | 0.51 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ITGAV | P06756 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7319731 | 0.95 | ITGB1 (0.58) | MMP2MMP9FKBP1AITGB1ITGA5 | |
| SCHEMBL6710652 | 0.88 | ITGB1 (0.57) | MMP2MMP9FKBP1AITGB1ITGA5 | |
| SCHEMBL7070012 | 0.85 | FKBP1A (0.59) | MMP2MMP9FKBP1AITGB1ITGA5 | |
| SCHEMBL7361018 | 0.83 | ITGA4 (0.55) | MMP2MMP9FKBP1AITGB1ITGA5 | |
| SCHEMBL5690625 | 0.83 | MAPK1 (0.66) | ITGB1ITGA5ITGA4L3MBTL1ALDH1A1 | |
| SCHEMBL3849601 | 0.83 | ITGA4 (0.60) | FKBP1AITGB1ITGA5ITGA4RAB9A | |
| SCHEMBL5690691 | 0.83 | FKBP1A (0.56) | MMP2MMP9FKBP1AITGB1ITGA5 | |
| SCHEMBL5690857 | 0.82 | ITGB1 (0.56) | MMP2MMP9FKBP1AITGB1ITGA5 | |
| SCHEMBL5487316 | 0.82 | FKBP1A (0.61) | MMP2MMP9FKBP1AITGB1ITGA4 | |
| SCHEMBL7069672 | 0.82 | ITGB1 (0.64) | MMP2MMP9FKBP1AITGB1ITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1001972-A1 | SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999006431-A1 | SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 1999-02-11 | — | — | WO | claimed |
| US-6492421-B1 | BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA | ATHENA NEUROSCIENCES, INC. | 2002-12-10 | — | — | US | disclosed |